ArticleJournal of experimental & clinical cancer research : CR2010

Cancer cell sensitivity to bortezomib is associated with survivin expression and p53 status but not cancer cell types.

Xiang Ling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.